Showing results (421-430 of 21,758) with videos related to
Sort By:
Pageof 2,176
British Journal of Cancer|May 30, 2015
Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancerC-H Koh, N Bhoo-Pathy, K-L Ng, et al.British Journal of Cancer|July 15, 2015
Clinical and genomic analysis of a randomised phase II study evaluating anastrozole and fulvestrant in postmenopausal patients treated for large operable or locally advanced hormone-receptor-positive breast cancerNathalie Quenel-Tueux, Marc Debled, Justine Rudewicz, et al.British Journal of Cancer|July 15, 2015
Impact of p16 status on pro- and anti-angiogenesis factors in head and neck cancersP Baruah, M Lee, P O G Wilson, et al.British Journal of Cancer|July 15, 2015
Understanding cervical screening non-attendance among ethnic minority women in EnglandL A V Marlow, J Wardle, J WallerBritish Journal of Cancer|July 17, 2015
Clinical utility of the IHC4+C score in oestrogen receptor-positive early breast cancer: a prospective decision impact studyB Yeo, L Zabaglo, M Hills, et al.British Journal of Cancer|July 17, 2015
Axl receptor tyrosine kinase is a potential therapeutic target in renal cell carcinomaH Yu, R Liu, B Ma, et al.British Journal of Cancer|July 17, 2015
Gene therapy with SOCS1 for gastric cancer induces G2/M arrest and has an antitumour effect on peritoneal carcinomatosisRie Natatsuka, Tsuyoshi Takahashi, Satoshi Serada, et al.British Journal of Cancer|June 10, 2015
Differential p16/INK4A cyclin-dependent kinase inhibitor expression correlates with chemotherapy efficacy in a cohort of 88 malignant pleural mesothelioma patientsC J Jennings, B Murer, A O'Grady, et al.British Journal of Cancer|June 10, 2015
Association between cytosolic expression of BRCA1 and metastatic risk in breast cancerW L Santivasi, H Wang, T Wang, et al.British Journal of Cancer|June 10, 2015
miR-30e* is an independent subtype-specific prognostic marker in breast cancerF D'Aiuto, M Callari, M Dugo, et al.Pageof 2,176